These effects, along with a prior report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 assist the strategy of focusing on ACKR3 as a novel way to modulate the opioid method, which could open up new therapeutic avenues for opioid-relevant Problems. At that time, Microsoft https://billu714iga4.activosblog.com/profile